A comprehensive view of Horizon Therapeutics Plc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Amgen to lay off 350 workers at Horizon Therapeutics following their US$27.8B acquisition of the company; Amgen assures job placement for 80% of Horizon's workforce and supportive transition for those affected
Published: October 24, 2023 by Chicago Tribune (IL)
Leerink upgrades Amgen to outperform, citing promising pipeline developments and recent acquisition of Horizon Therapeutics; substantial earnings boost also expected, as well as multiple market opportunities in obesity, inflammation and oncology sectors
Published: October 18, 2023 by Zacks Investment Research
Amgen completes Horizon Therapeutics buyout for US$27.8B; Horizon's Tepezza, Krystexxa and Uplizna expected to enhance Amgen’s autoimmune portfolio
Published: October 06, 2023 by FiercePharma
Amgen and Horizon Therapeutics reach a consent order agreement with the FTC, resolving an administrative lawsuit and clearing the way for Amgen’s acquisition of Horizon; the acquisition is expected to finalize early in Q4 2023
Published: September 01, 2023 by Business Wire
FTC pauses legal proceedings to block Amgen's proposed takeover of Horizon Therapeutics, mulling potential settlement; possible resolution is under consideration until Sept. 18
Published: August 28, 2023 by FiercePharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count